Dolby Laboratories (DLB) Stock Falls on Q1 2026 Earnings

Dolby Laboratories (DLB) reported Q1 2026 results with a mixed top-line beat and weaker profitability.

Total revenue: $346.7 million (down 2.9% year-over-year; beat the estimate of $335.4 million).

Cost of sales: $43.2 million (up 6.0% year-over-year).

Profitability:

Gross profit: $303.5 million (down 4.0% year-over-year).

Operating profit: $62.2 million (down 22.2% year-over-year).

Net income attributable to common shareholders: $53.3 million (down 21.4% year-over-year).

Diluted earnings per share: $0.55 (down 21.4% year-over-year and below the estimate of $0.89).

Cash flow and balance sheet items:

Cash from operating activities: -$18.9 million (declined 117.7% year-over-year).

Purchases of property, plant and equipment: -$16.2 million (up 139.6% year-over-year).

Cash and cash equivalents: $643.8 million (up 23.6% year-over-year).

Total liabilities: $589.3 million (down 8.2% year-over-year).

Market reaction:

Shares fell about 3.03% after the release.

Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.

Dolby Laboratories Insider Trading Activity

Dolby Laboratories insiders have traded $DLB stock on the open market 20 times in the past 6 months. Of those trades, 0 have been purchases and 20 have been sales.

Here’s a breakdown of recent trading of $DLB stock by insiders over the last 6 months:

KEVIN J YEAMAN (President and CEO) has made 0 purchases and 11 sales selling 179,583 shares for an estimated $12,322,295.
MARK ANDREW SHERMAN (EVP, Gen. Counsel & Secretary) has made 0 purchases and 4 sales selling 16,100 shares for an estimated $1,079,438.
JOHN D COULING (SVP, Entertainment) has made 0 purchases and 2 sales selling 13,437 shares for an estimated $907,582.
SHRIRAM REVANKAR (SVP, Advanced Technology Group) has made 0 purchases and 2 sales selling 10,000 shares for an estimated $721,090.
TONY A PROPHET sold 3,300 shares for an estimated $223,904

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Dolby Laboratories Hedge Fund Activity

We have seen 196 institutional investors add shares of Dolby Laboratories stock to their portfolio, and 203 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

GOLDMAN SACHS GROUP INC added 610,205 shares (+184.9%) to their portfolio in Q3 2025, for an estimated $44,160,535
SCHRODER INVESTMENT MANAGEMENT GROUP removed 524,014 shares (-64.9%) from their portfolio in Q3 2025, for an estimated $37,922,893
FRONTIER CAPITAL MANAGEMENT CO LLC removed 510,801 shares (-41.3%) from their portfolio in Q3 2025, for an estimated $36,966,668
AQR CAPITAL MANAGEMENT LLC removed 444,614 shares (-25.6%) from their portfolio in Q3 2025, for an estimated $32,176,715
FIRST TRUST ADVISORS LP added 281,214 shares (+22.7%) to their portfolio in Q3 2025, for an estimated $20,351,457
MORGAN STANLEY removed 238,632 shares (-3.4%) from their portfolio in Q3 2025, for an estimated $17,269,797
PACER ADVISORS, INC. added 219,901 shares (+98.2%) to their portfolio in Q3 2025, for an estimated $15,914,235

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Dolby Laboratories Congressional Stock Trading

Members of Congress have traded $DLB stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $DLB stock by members of Congress over the last 6 months:

REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 09/11 and 2 sales worth up to $30,000 on 09/25, 08/04.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

Dolby Laboratories Analyst Ratings

Wall Street analysts have issued reports on $DLB in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Rosenblatt issued a "Buy" rating on 11/19/2025
Barrington Research issued a "Outperform" rating on 11/19/2025
Tigress Financial issued a "Buy" rating on 08/15/2025

To track analyst ratings and price targets for Dolby Laboratories, check out Quiver Quantitative's $DLB forecast page.

Dolby Laboratories Price Targets

Multiple analysts have issued price targets for $DLB recently. We have seen 4 analysts offer price targets for $DLB in the last 6 months, with a median target of $87.5.

Here are some recent targets:

Patrick Sholl from Barrington Research set a target price of $90.0 on 01/26/2026
Steven Frankel from Rosenblatt set a target price of $85.0 on 01/22/2026
Vikram Kesavabhotla from Baird set a target price of $74.0 on 09/05/2025
Ivan Feinseth from Tigress Financial set a target price of $114.0 on 08/15/2025